Clinical Trials Directory

Trials / Unknown

UnknownNCT03149250

Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia

Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia - a Cross-sectional Study

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Goethe University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers

Summary

The study aims to investigate the impact of preeclampsia on hemostasis.

Detailed description

In comparison to healthy pregnant women and non-pregnant woman, this study analyses parameters of primary hemostasis and plasmatic coaguation in preeclamptic pregnant woman. Detailed analyses of the platelet function is performed using the Multiple Electrode Aggregometry, detailed analyses of the plasmatic coagulation syste is performed by isolated coaguation factor analyses and conventional coagulation analyses.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAggregometry, Monitoring of plasmatic hemostasisMultiple Electrode Aggregometry using the Multiplate system Coagulation factor analyses (FXIII, FVIII, vWF) Parameters of conventional coagulation testing (aPTT, INR, Platelet count)

Timeline

Start date
2017-09-01
Primary completion
2017-12-31
Completion
2018-02-01
First posted
2017-05-11
Last updated
2017-08-22

Source: ClinicalTrials.gov record NCT03149250. Inclusion in this directory is not an endorsement.